Search Results: immunotherapy

• Health & Medicine

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma. A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

3 May 2017

• Health & Medicine

CRISPR genome editing and immunotherapy – the early adopter

How is CRISPR genome editing helping harness the power of immunotherapy? How is CRISPR genome editing helping harness the power of immunotherapy?

21 April 2017

• Science & Technology
• Health & Medicine

Blood tests, microbes, immunotherapy and more: AACR 2017’s hottest topics

At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics. At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.

13 April 2017

• Health & Medicine

Blocking growth of tumour blood vessels could boost immunotherapy

Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies. Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies.

12 April 2017

• Science & Technology

Study suggests why an immunotherapy drug works in some melanoma patients but not in others

Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread. Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread.

12 April 2017

• Health & Medicine

Immunotherapy drug too costly for head and neck cancer

An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog. An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog.

12 April 2017

• Health & Medicine

Long term benefits of immunotherapy emerging for some patients, though key questions remain

A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research. A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.

10 April 2017

• Health & Medicine

Scrambled DNA inside tumours might hinder cancer immunotherapy

Cancer treatments that harness the power of the immune system might be less effective in patients whose tumours carry incorrectly packaged DNA. Cancer treatments that harness the power of the immune system might be less effective in patients whose tumours carry incorrectly packaged DNA.

20 January 2017

• Health & Medicine

Immunotherapy drug extends lives of advanced lung cancer patients

A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects. A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects.

13 December 2016

• Science & Technology
• Health & Medicine

NCRI Cancer Conference 2016: Day 4 – liver cancer, obesity, immunotherapy poo predictions and more

Read our final roundup from this year's NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work. Read our final roundup from this year's NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work.

10 November 2016

• Health & Medicine

Weight loss condition provides clue to why some immunotherapy treatments fail

A weight loss condition frequently seen in cancer patients could provide answers as to why certain immunotherapy treatments fail in some patients. A weight loss condition frequently seen in cancer patients could provide answers as to why certain immunotherapy treatments fail in some patients.

9 November 2016

• Health & Medicine

Gut microbes linked to immunotherapy response in melanoma patients

Patients with malignant melanoma are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria. Patients with malignant melanoma are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria.

7 November 2016